[1] Zaehres H,Scholer HR.Induction of pluripotency: from mouse to human.Cell. 2007;131:834-835.[2] Wu Z,Chen J,Ren J,et al.Generation of pig induced pluripotent stem cells with a drug-inducible system.Mol Cell Biol.2009;1(1):46-54.[3] 魏小元,徐雍羽,王敏,等.c-Myc对诱导性多能干细胞的诱导效率及全能性影响的研究[J].中国细胞生物学学报,2014,36(4): 430-437.[4] Verdi J,Tan A,AlirezaS H.Endometrial stem cells in regeneratve medicine.J Biol Eng.2014;8:20. [5] Takahashi K,Yamanaka S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell.2006;126:663-676.[6] Chen HM,Delong CJ,Bame M,et al.Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from biopolar disorder patients.Transl Psychiatry.2014;4:e375.[7] Cai S,Chan YS,Yan DK.Induced pluripotent stem cells and neurological disease models.Acta Physiologica Sinica. 2014;66(1):55-66.[8] Saric T,Hescheler J.Stem cells and nmclear reprogramming. Minim Invasive Ther Allie(I Technol. 2008;17(2):64-78.[9] Yu J,Vodyanik MA,Smuga-Otto K,et al.Induced plu¬ripotent stem cell lines derived from human somatic cells.Science. 2007;318:1917-1920.[10] Wernig M,Meissner A,Foreman R,et al.In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.Nature.2007; 448(7151):318-324.[11] Brambrink T,Foreman R,Welstead GG,et al.Sequential expression of pluripotency markers during direct reprogramming of mouse somatic ceils.Cell Stem Cell. 2008;2(2):151-159.[12] Blelloch R,Venere M,Yen J,et al.Generation of induced pluripotent stem cells in the absence of drug selection.Cell Stem Cell.2007;1(3):245-247.[13] Meissner A,Wernig M,Jaenisch R.Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.Nat Biotechnol.Nat Biotechnol. 2007;25(10):1177-1181.[14] 彭静,黄聪,蒋思文.诱导多潜能干细胞的临床应用进展[J].科学通报,2013,59(9):763-768.[15] Narazaki G,Uosaki H,Teranishi M,et al.Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.Circulation.2008;118:498-506.[16] Yokoo N,Baba S,Kaichi S,et al.The effects of cardioactive drugs on cardiomyocytess derived from human induced pluripotent stem cells.Biochem Biophys Res Commun. 2009; 387(3):482-488.[17] Dimos JT,Rodolfa KT,Niakan KK,et al.Induced pluripotentstem cells generated from patients with ALS can bedifferentiated into motor neurons.Science.2008; 321(7):1218-1221.[18] Soldner F,Hockemeyer D,Beard C,et al.Parkinson’sdisease patient-derived induced pluripotent stem cells free ofviral reprogramming factors.Cell.2009;136(3):964-977.[19] Gore A,Li Z,Fung HL,et al.Somatic coding mutations inhuman induced pluripotent stem cells.Nature.2011;471(7336):63-67.[20] Hussein SM,Batada NN,Vuoristo S,et al.Copy numbervariation and selection during reprogramming to pluripotency.Nature.2011;471(7336):58-62.[21] Takahashi K,Tanabe K,Ohnuki M,et al.Induction ofpluripotent stem cells from adult human fibroblasts bydefined factors. Cell.2007;131(5):861-872.[22] Ye Z,Zhan H,Mali P,et al.Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.Blood.2009;114:5473-5480.[23] Choi SM,Kim Y,Liu H,et al.Liver engraftment potential of hepatic cells derived from patient-speific induced pluripotent stem cells.Cell Cycle.2011;10(15):2423-2427.[24] Maehr R,Chen S,Snitow M,et al.Generation of ploripotent stem cells from patients with type 1 diabetes.Proc Natl Acad Sci USA.2009;106(37):15768-15773.[25] Lee G,Papapetrou EP,Kim H,et al.Modelling pathogenesis and treatment of dysautonomia using patient-specific iPSCs.Nature.2009;461(7262):402-406.[26] Hanna J,Werning M,Markoulaki S,et al.Treatment of sickle cell anemia mouse model with ips cells generated from autologous skin.Science.2007;318(5858):1920. [27] Dimos JT,Rodolfa KT,Niakan KK,et al.Induced pluripotentstem cells generated from patients with ALS can bedifferentiated into motor neurons.Science.2008; 321(7):1218-1221.[28] Ebert AD,Yu J Y,Rose Jr FF,et al.Iduced pluripotent stem cell from a spinal muscular atrophy patient. Nature. 2009;475: 277-280.[29] Hanna J,Wernig M,Markoulaki S,etal.Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.Science.2007;318:1920 -1923.[30] Li J,Pan GJ.Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells.J Hematol Oncol.2014;7:50. [31] Gunewardene N,Bergen NV,Crombie D,et al.Directing human induced pluripotent stem cells into a neurosensory lineage for auditory neuron replacement.Biores Open Access.2014; 3(4):162-175.[32] 顾卫娟,李小荣,张凤祥,等.iPS细胞移植对猪心肌梗死后梗死区心肌超微结构的影响[J].中华全科医学,2013,11(12): 1829- 1889.[33] Bilousova G,Jun du H,King KB,et al.Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and vivo.Stem Cells.2011;29(2): 206-216.[34] 邢舰誉,张宇,陈墨,等.糖浓度及BMP4对小鼠诱导型多能干细胞成骨作用的研究[J].中国细胞生物学学报,2014,36(5):1-9. [35] Werning M,Zhao J P,Pruszak J,et al.Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve sysmptoms of rats with Parkinson’s disease.Proc Natl Acad Sci USA.2008;105(15):5856-5861.[36] Liu YX,Rahaman MN,Bal S.Modulating notochordal differentiation of human induced pluripotent stem cells using natural nucleus pulposus tissue matrix.PLoS One. 2014;9(7): e100885.[37] Faulkner-Jones A,Greenhough S,King JA,et al.Development of a valve-based cell printer for the formation of human embryonic stem cell spheroid aggregates. Biofabrication. 2013;5(1):015013.[38] Maechr R,Chen S,Snitow M,et al.Generation of pluripotent stem cells from patients with type 1 diabetes.Proc Natl Acad Sci USA.2009;106:15768-15773.[39] Lippmann ES,Azarin SM,Kay JE,et al.Derivation of blood-brain barrier endothelial cells from human plouripotent stem cells.Nat Biotechnol.2012;30(8):783-791.[40] Zhao TB,Zhang ZN,Rong ZL,et al.Immunogenicity of induced pluripotent stem cells.Nature.2011;474:212-215.[41] 张曦,张诚.造血干细胞移植中的输血相关问题[J].中国输血杂志, 2013,26(3):103.[42] 赖永榕.造血干细胞移植治疗地中海贫血的经验[J].内科急危重症杂志,2014,20(1):6-8.[43] 李续娥,李峰.地中海贫血骨髓移植中造血干细胞状态及功能的研究[J].华南师范大学学报,2013,45(1):10-13.[44] Narva E,Autio R,Rahkonen N,et al.High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygos¬ity. Nat Biotechnol.2010;28:371-377.[45] Ben-Porath I,Thomson MW,Carey VJ,et al.An embryonicstem cell-like gene expression signature in poorly differentiatedaggressive human tumors.Nat Gene.2008; 40(5): 499-450.[46] Cartwright P,Mclean C,Sheppard A,et al.Lif/stat3 controls ES cell self-renewall and pluripotency by a Myc-dependent mechanism.Development.2005;132(5):885-896.[47] Schoenhals M,Kassambara A,De Vos J,et al.Embryonic stem cell markers expression incancers.Biochem Biophys Res Commun.2009;383(2):157-162.[48] Nakagawa M,Koyanagi M,Tanabe K,et al.Generation ofinduced pluripotent stem cells without Myc from mouse and human fibroblasts.Nat Biotechnol.2008;26(1):101-106. [49] Okita K,Ichisaka T,Dr Yamanaka S.Generation of germ-line competent induced pluripotent stem cells].Nature.2007; 448:313-317.[50] Miyoshi N,Ishii H,Nagano H,et al.Reprogramming of mouse andhuman cells to pluripotency using mature microRNAs.Cell Stem Cell.2011;8(6):633-638.[51] Wu S,Wu Y,Zhang X,Capecchi MR.Effcient germ-line transmission obtained with transgene-free induced pluripotent stem cells.Proc Natl Acad Sci USA.2014;111(29): 10678-10683. |